View all trials
Are you a member? Sign in above to view additional information
  • Study title
    A Phase 2b open-label, single-arm study to evaluate pharmacokinetics, efficacy, safety and tolerability of letermovir in pediatric participants from birth to <18 years of age at risk of developing CMV infection and/or disease following allogeneic HSCT
  • Protocol ID
    MK-8228-030
  • Disease
    Disease Type Disease Subtype
  • Eligibility criteria
  • Study Status
    Open
  • Location(s)
    Queensland Children's Hospital
    • Centre Study Status:
      Open
    • Notes:
  • Phase
    Phase 2
  • Study type
    Treatment
  • Diagnosis stage
  • Study open date
    N/A
  • Study close date
    N/A
  • Study chair
  • Sponsor
Back to search results